JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a biotech company ...

Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...

An estimated 1 to 3 million people suffer from POTS. In addition to POTS, Knowles struggles with Sjögren’s syndrome and mast ...

The Building Digital UK agency and Department for the Economy (DfE) have this week begun the supplier procurement phase of ...

Plans have been submitted to install a phone mast in a small village south of Shrewsbury. Atlas Tower Group has submitted ...

Caroline Quinn, 25, from Boston, MA, faces unique challenges in love due to a rare immune disease and severe allergies. With ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: Guggenheim ...

A woman with over 100 allergies has divided much of the internet after showing how she orders food at a restaurant. Jenna ...

Caroline Quinn, 25, has shared how suffering from mast cell activation syndrome (MCAS) has affected many aspects of her life ...